ArticleCureus2025
A Comparative Study on Calprotectin Concentration in Periodontitis Patients Before and After Non-surgical Periodontal Therapy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Salivary Biomarker Profile in Periodontal Diseases: A Cross-Sectional Study on Leptin, Adiponectin, and Calprotectin.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Numerous inflammatory mediators exist in body secretions like gingival crevicular fluid (GCF) during periodontitis. One such inflammatory mediator is calprotectin, a protein which is released from leukocytes and other inflammatory cells. Aims This study aimed to compare the concentration of calprotectin in the GCF of individuals with and without periodontitis, as well as in the GCF, serum, and saliva of periodontitis patients before and after non-surgical periodontal therapy. Materials and methods Subjects were categorized into two groups: Group A included 40 healthy subjects without periodontitis and Group B included 40 subjects with stage 2 grade B periodontitis subjects. Clinical parameters along with calprotectin concentration in both groups were recorded at baseline and compared. All subjects in Group B received non-surgical periodontal therapy (NSPT). Three months following therapy, periodontal parameters and calprotectin concentrations in GCF, serum, and saliva were re-assessed, and a comparison was made with the values obtained before therapy. Results At baseline, inter-group comparison revealed that the calprotectin levels in GCF of Group A subjects were significantly lower than Group B subjects. On intra-group comparison within Group B subjects, three months following NSPT, there was a reduction in the concentration of calprotectin in GCF, which was statistically significant. Conclusion Calprotectin in GCF can serve as a diagnostic biomarker and maybe used to assess the response to treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.